Mark Alan Smith - Dec 31, 2021 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Dec 31, 2021
Transactions value $
$4,401
Form type
4
Date filed
1/3/2022, 03:25 PM
Previous filing
Jul 2, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $4.4K +2.66K +21.66% $1.66 14.9K Dec 31, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)